Hanall Biopharma Co., Ltd. (KRX: 009420)
South Korea
· Delayed Price · Currency is KRW
45,950
+2,600 (6.00%)
Oct 14, 2024, 2:29 PM KST
27.82% (1Y)
Market Cap | 2.37T |
Revenue (ttm) | 130.37B |
Net Income (ttm) | -6.19B |
Shares Out | 50.71M |
EPS (ttm) | -122.33 |
PE Ratio | n/a |
Forward PE | 116.44 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 2,565,908 |
Open | 44,250 |
Previous Close | 43,350 |
Day's Range | 42,750 - 46,650 |
52-Week Range | 28,500 - 46,750 |
Beta | 0.84 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 13, 2024 |